Sun Pharmaceutical Industries Ltd. | SUNPHARMA | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
90,479
34,790
38,102
50,096
27,994
Cash flow Operating Act...
Cash flow Operating Activities
70,82239,07221,96565,54861,704
Investments in PPE
Investments in PPE
-36,929-19,608-32,128-15,420-11,701
Cash flow Investing Act...
Net cash used for Investment Activities
-42,216-33,708-6,813-25,8885,362
Dividend Paid
Dividend Paid
2,8899,75814,24216,82815,862
Cash flow Financing Act...
Net cash provided by Financing Activities
-22,854-15,393-27,305-57,151-59,805
Cash at beginning of period
Cash at beginning of period
80,31786,42479,06570,62356,766
Cash at end of period
Cash at end of period
86,42479,06570,62356,76662,730
Free Cash Flow
Free Cash Flow
33,894
19,464
-10,164
50,128
50,002